Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Endothelial Function in HIV
NCT00986999Phase 3Terminated
- Sponsor
- University of Hawaiʻi
- Start
- Sep 2009
- Primary completion
- Jan 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of rosuvastatin in cardiovascular disease (CVD) (2 arms), sponsored by University of Hawaiʻi. Primary endpoint: Flow Mediated Dilatation of the Brachial Artery at 3 months. Started Sep 2009; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00986999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00986999.